CogState Ltd
ASX:CGS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CogState Ltd
Gross Profit
CogState Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CogState Ltd
ASX:CGS
|
Gross Profit
$31.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
4DMedical Ltd
ASX:4DX
|
Gross Profit
AU$5.3m
|
CAGR 3-Years
103%
|
CAGR 5-Years
140%
|
CAGR 10-Years
N/A
|
|
|
Pro Medicus Ltd
ASX:PME
|
Gross Profit
AU$248.4m
|
CAGR 3-Years
33%
|
CAGR 5-Years
33%
|
CAGR 10-Years
27%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
Gross Profit
AU$41.6m
|
CAGR 3-Years
6%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
A
|
Artrya Ltd
ASX:AYA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BlinkLab Ltd
ASX:BB1
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CogState Ltd
Glance View
Cogstate Ltd. is a global cognitive science company. The firm provides computerized cognitive tests across various domains and support electronic clinical outcome assessment (eCOA) solutions. The firm's segment includes Clinical trials, Healthcare and Research. In the Clinical trials segment, the Company's technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians to assess cognitive decline. Research segment offers various research studies and academic collaborations across various indication of diseases.
See Also
What is CogState Ltd's Gross Profit?
Gross Profit
31.7m
USD
Based on the financial report for Dec 31, 2025, CogState Ltd's Gross Profit amounts to 31.7m USD.
What is CogState Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
12%
Over the last year, the Gross Profit growth was 12%. The average annual Gross Profit growth rates for CogState Ltd have been 14% over the past three years , 19% over the past five years , and 12% over the past ten years .
